Menu

Funding Briefs

NIOSH Narrows Focus, Increases Award The federal National Institute for Occupational Safety and Health has sweetened the pot in its search for applied scientists interested in conducting research on job-related risk factors. The agency has increased the annual stipend for its Special Emphasis Research Career Awards to $50,000, up from $30,000, and has lowered its requirements for research experience. The nonrehewable awards, begun in 1984, must now support training in applied or clinical—

Oct 16, 1989
The Scientist Staff

NIOSH Narrows Focus, Increases Award

The federal National Institute for Occupational Safety and Health has sweetened the pot in its search for applied scientists interested in conducting research on job-related risk factors. The agency has increased the annual stipend for its Special Emphasis Research Career Awards to $50,000, up from $30,000, and has lowered its requirements for research experience. The nonrehewable awards, begun in 1984, must now support training in applied or clinical—not basic—research with a multidisciplinary bent. “We’re not interested in supporting basic research unless it has immediate application,” says Joseph M. Lary, research grants program officer.

Applicants must have a doctorate and some research experience, but must not yet be above the rank of associate professor. The work must be clearly linked to occupational health and safety and must make an original contribution to applied technical knowledge for identifying, evaluating, or controlling hazards. The awardee’s institution receives up to $50,000 per year for salary, fringe benefits, technical assistance, equipment, supplies, travel, and other costs. Up to 8% more can be put toward indirect costs. Deadlines are November 1, March 1, and July 1.

The changes in this year’s criteria are meant to attract more applicants. NIOSH can support about seven new scientists a year, and about 15 overall, but the agency usually funds only three or four. Last year all three who applied got grants. So this year the agency eliminated the requirement that applicants have two years of postdoctoral research experience, and fixed the award period at three years. The changes seem to be having the desired effect, says Lary. Six scientists have applied during the first round; there are two rounds left in the year. For more information, contact Joseph M. Lary, NIOSH, CDC; 1600 Clifton Road, N.E., Bldg. 1, Room 3053, MS D-30, Atlanta, Ga.; (404) 639-3343.

Scholarships To Study In France

The French Ministry of Foreign Affairs, through its Chateaubriand Scholarships, sponsors visits of six to 18 months by young scientists to French laboratones. The program offers about 20 opportunities in the life and physical sciences and 10 in the social sciences for doctoral students and postdoctoral fellows from the U.S. who have completed their degrees within the past three years. The six-year-old program seeks to stimulate collaborative research and requires a formal, written invitation from a French laboratory, plus other supporting materials that demonstrate the scientist’s capabilities and the significance of the work planned. Each year about 40 apply for these scholarships, which cover round-trip travel and health insurance and pay $1,100 per month. Applications are due January 31.

The program is one of several that support long- and short-term visits to France by U.S. students and faculty, There are also programs for French scientists wishing to work in the U.S. For more information, contact A. Prakash, French Scientific Mission, Embassy of France, 4101 Reservoir Rd., N.W., Washington, D.C. 20007-2176; (202) 944-6242.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.